No need for phar­ma­cist an­tibi­otic Rx

Pharmacy Daily - - News -

QUEENS­LAND’S phar­ma­cist pre­scrib­ing trial should be redi­rected to fo­cus on chronic con­di­tions rather than the pro­vi­sion of an­timi­cro­bial med­i­ca­tions, a NSW hos­pi­tal phar­ma­cist be­lieves.

Speak­ing to Phar­macy Daily, NSW An­timi­cro­bial Stew­ard­ship Phar­ma­cist Net­work Chair, Aryan Sha­habi-Sir­jani, warned the trial could in­crease an­timi­cro­bial re­sis­tance in Aus­tralia.

Sha­habi-Sir­jani ar­gued that while he sup­ported the ex­pan­sion of phar­ma­cists’ scope of prac­tice into ar­eas where there are gaps in health ser­vices, he said the pre­scrib­ing of an­tibi­otics for uri­nary tract in­fec­tions (UTIs) was not ap­pro­pri­ate.

“Our con­cern is with an­timi­cro­bial re­sis­tance,” he said.

“There isn’t re­ally a need or gap in prac­tice where we need com­mu­nity phar­ma­cists pre­scrib­ing an­tibi­otics.

“There are cer­tainly other ar­eas where com­mu­nity phar­ma­cists should be pre­scrib­ing [such as] in chronic care cases where pa­tients prob­a­bly don’t need to see the GP for a re­peat script.

“But re­ally UTIs are acute care and mis­treat­ing UTIs can have con­se­quences on pa­tient care, and of course an­timi­cro­bial re­sis­tance has life-long con­se­quences on both in­di­vid­ual pa­tients and the com­mu­nity, so we don’t think we should be ex­pand­ing an­timi­cro­bial pre­scrib­ing to phar­ma­cists.”

Sha­habi-Sir­jani added that other ju­ris­dic­tions where an­tibi­otics have been avail­able over-the-counter, have seen “dis­pro­por­tion­ate lev­els of re­sis­tance”, not­ing that trimethor­pim, one of the med­i­ca­tions that has been ap­proved for use in trial al­ready has a 20% re­sis­tance rate within the com­mu­nity.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.